CytoDyn Inc.
Pharmaceutical company · Vancouver, Washington, United States · OTC: CYDY
CytoDyn Inc. is a pharmaceutical company headquartered in Vancouver, Washington, United States. Its shares trade on OTC under the ticker CYDY. It has reported private securities offerings to the US SEC, most recently $19 million sold in a notice filed in 2026.
CytoDyn at a glance
What does CytoDyn do?
Private fundraising reported to the SEC
32 Form D notices; the most recent reported $18.6 million sold (2026).
Frequently asked questions about CytoDyn
Where is CytoDyn headquartered?
CytoDyn Inc. is headquartered in Vancouver, Washington, United States.
What does CytoDyn do?
CytoDyn Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is CytoDyn a public company?
Yes. CytoDyn Inc. trades on OTC under the ticker CYDY.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.